Semaglutide & Tirzepatide belong to a class of medications called Glucagon-like peptide 1-(GLP-1 analogs) and (GIP) glucose-dependent insulinotropic polypeptides. These are both naturally occurring hormones found within our bodies (mainly our gut) and are released in response to food. It causes reduced appetite, insulin release and interacts with the parts of the brain that suppress our appetite and signal us to feel full. When used in conjunction with diet and exercise, it can cause significant weight loss. Tirzepatide (Zepbound) is the first and only approved treatment activating two incretin hormone receptors, GIP and GLP-1, to tackle an underlying cause of excess weight. Adults taking Zepbound in a clinical trial lost on average 48 lb. at the highest dose!